Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;288(1):149-160.
doi: 10.1111/imr.12736.

T-bet+ memory B cells: Generation, function, and fate

Affiliations
Review

T-bet+ memory B cells: Generation, function, and fate

James J Knox et al. Immunol Rev. 2019 Mar.

Abstract

B cells expressing the transcription factor T-bet have emerged as participants in a number of protective and pathogenic immune responses. T-bet+ B cells characteristically differentiate in response to combined Toll-like receptor and cytokine signaling, contribute to protective immunity against intracellular pathogens via IgG2a/c production and antibody-independent mechanisms, and are prone to produce autoantibodies. Despite recent advances, a number of questions remain regarding the basic biology of T-bet+ B cells and their functional niche within the immune system. Herein, we review the discovery and defining characteristics of the T-bet+ B cell subset in both mice and humans. We further discuss their origins, the basis for their persistence, and their potential fate in vivo. Evidence indicates that T-bet+ B cells represent a distinct, germinal center-derived memory population that may serve as an important therapeutic target for the improvement of humoral immunity and prevention of autoimmunity.

Keywords: T-bet+ B cells; humoral autoimmunity; intracellular pathogens; memory B cells; plasma cells; tissue-resident memory B cells.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare no conflict of interest.

Figures

Figure 1:
Figure 1:
Origin, fate, and function of T-bet+ B cells: Microorganisms and apoptotic debris can trigger signaling downstream of nucleic acid receptors. Based on the cytokine milieu present, these signals can induce (via IFNg/IL-21) or inhibit (via IL-4) T-bet expression in B cells. Evidence suggests a requirement for cognate help and germinal center-dependent formation of T-bet+ B cells, but T-bet-expressing B cells can develop extrafollicularly under certain conditions. T-bet expression drives class switching to IgG2a/c in mice or IgG1 in humans, whereas T-bet- B cells favor other isotypes, such as IgA. T-bet+ memory B cells are persistent, most likely due to self-renewal, and can be progenitors of plasma cells or, upon re-challenge, differentiate into other effector cell lineages. Because of their persistence and roles promoting antibody secretion and other B cell effector functions, T-bet+ B cells are key players in pathogenic and protective humoral immunity.

References

    1. Hardy RR and Hayakawa K. A developmental switch in B lymphopoiesis. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 11550–11554. 1991/December/15. - PMC - PubMed
    1. Hayakawa K, Hardy RR, Herzenberg LA, et al. Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. Journal of Experimental Medicine 1985; 161: 1554–1568. - PMC - PubMed
    1. Allman DM, Ferguson SE, Lentz VM, et al. Peripheral B cell maturation. II. Heat-stable antigen(hi) splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J Immunol 1993; 151: 4431–4444. 1993/November/01. - PubMed
    1. Martin F and Kearney JF. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a “natural immune memory”. Immunol Rev 2000; 175: 70–79. 2000/August/10. - PubMed
    1. Oliver AM, Martin F, Gartland GL, et al. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997; 27: 2366–2374. 1997/October/28 DOI: 10.1002/eji.1830270935. - DOI - PubMed

Publication types